A combination therapy with fludarabine, mitoxantrone and rituximab induces complete immunophenotypical remission in B-cell prolymphocytic leukaemia

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of hematology 2009-01, Vol.88 (1), p.85-88
Hauptverfasser:	Tempescul, Adrian, Feuerbach, Johanna, Ianotto, Jean-Christophe, Dalbies, Florence, Marion, Veronique, Le Bris, Marie-Josée, De Braekeleer, Marc, Berthou, Christian
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Murine-Derived Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - therapeutic use Female Hematology Humans Immunophenotyping In Situ Hybridization, Fluorescence Letter to the Editor Leukemia, Prolymphocytic, B-Cell - drug therapy Male Medicine Medicine & Public Health Middle Aged Mitoxantrone - administration & dosage Mitoxantrone - therapeutic use Oncology Remission Induction Rituximab Vidarabine - administration & dosage Vidarabine - analogs & derivatives Vidarabine - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!